Addressing Steroid-Refractory Acute Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
Hematologic oncologist and clinical researcher Doris M. Ponce, MD, discusses strategies to prevent and treat graft-vs-host disease after allogeneic hematopoietic stem cell transplantation.